These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2534160)

  • 1. Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians, and controls.
    Metcalfe T; Bowen DM; Muller DP
    Neurochem Res; 1989 Dec; 14(12):1209-12. PubMed ID: 2534160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients.
    Blusztajn JK; Lopez Gonzalez-Coviella I; Logue M; Growdon JH; Wurtman RJ
    Brain Res; 1990 Dec; 536(1-2):240-4. PubMed ID: 2150771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
    Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.
    Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE
    Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin E in brains of patients with Alzheimer's disease and Down's syndrome.
    Muller DP; Metcalfe T; Bowen DM
    Lancet; 1986 May; 1(8489):1093-4. PubMed ID: 2871355
    [No Abstract]   [Full Text] [Related]  

  • 7. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.
    Arena A; Iyer AM; Milenkovic I; Kovacs GG; Ferrer I; Perluigi M; Aronica E
    Curr Alzheimer Res; 2017; 14(12):1305-1317. PubMed ID: 28720071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
    Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic dysfunction: simultaneous study of Alzheimer's and older Down's patients.
    Singh VK; Fudenberg HH; Brown FR
    Mech Ageing Dev; 1986-1987 Jan; 37(3):257-64. PubMed ID: 2952844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.
    Yates CM; Simpson J; Gordon A; Maloney AF; Allison Y; Ritchie IM; Urquhart A
    Brain Res; 1983 Nov; 280(1):119-26. PubMed ID: 6228286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid abnormalities in the brain in adult Down's syndrome and Alzheimer's disease.
    Brooksbank BW; Martinez M
    Mol Chem Neuropathol; 1989 Dec; 11(3):157-85. PubMed ID: 2534986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease.
    Yates CM; Simpson J; Gordon A
    Neurosci Lett; 1986 Apr; 65(2):189-92. PubMed ID: 2940479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
    Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral amyloidosis, ageing and Alzheimer's disease; a contribution from studies on Down's syndrome.
    Mann DM
    Neurobiol Aging; 1989; 10(5):397-9; discussion 412-4. PubMed ID: 2530459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E and Alzheimer's disease in subjects with Down's syndrome.
    Jackson CV; Holland AJ; Williams CA; Dickerson JW
    J Ment Defic Res; 1988 Dec; 32 ( Pt 6)():479-84. PubMed ID: 2976843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lectin histochemistry of cerebral microvessels in ageing, Alzheimer's disease and Down's syndrome.
    Mann DM; Purkiss MS; Bonshek RE; Jones D; Brown AM; Stoddart RW
    Neurobiol Aging; 1992; 13(1):137-43. PubMed ID: 1531863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dolichols are elevated in brain tissue from Alzheimer's disease, but not in urinary sediment from Alzheimer's disease and Down's syndrome.
    Wolfe LS; Ng Ying Kin NM; Palo J; Bergeron C; Kotila M; Varonen S
    Neurochem Pathol; 1985; 3(4):213-21. PubMed ID: 2938031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in Down's syndrome and Alzheimer's disease.
    Hayn M; Kremser K; Singewald N; Cairns N; Nemethova M; Lubec B; Lubec G
    Life Sci; 1996; 59(7):537-44. PubMed ID: 8761342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down's syndrome brain.
    Kida E; Choi-Miura NH; Wisniewski KE
    Brain Res; 1995 Jul; 685(1-2):211-6. PubMed ID: 7583250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders.
    Copp RP; Wisniewski T; Hentati F; Larnaout A; Ben Hamida M; Kayden HJ
    Brain Res; 1999 Mar; 822(1-2):80-7. PubMed ID: 10082886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.